How quickly and effectively a company can develop and implement novel process technologies increasingly shapes the overall cost, timeliness, and results of new ...
This chapter discusses how process development fits into a firm's larger competitive, technological, organizational, and operational environments and develops a...
This chapter examines changes in the institutional and technological arenas in which pharmaceutical companies operate to highlight the competitive challenges th...
This chapter discusses how process development capabilities influence cost, development speed, and product innovation in pharmaceuticals....
This chapter looks at the evolution of product and process development in the pharmaceutical industry and describes different learning strategies that are requi...
A challenge facing many companies is to create a development process that is fast, efficient, and capable of generating high-quality process designs. This chapt...
In this chapter, the author presents a conceptual framework for learning across development projects and examines the approaches of four different biotechnology...
This chapter presents a series of case studies that examine unique management dilemmas related to process development, illustrating the broad organizational con...
Established pharmaceutical firms and new entrants alike have pursued various strategies for improving their process development capabilities in an arena in whic...
Superior development performance requires different practices in different environments. This chapter explores how two strategies-learning by doing and learning...
For more than twenty-five years, the biotechnology industry has been host to a profound and important experiment: the fusion of science and business. The signif...
Too often discussions in both the popular press and academic studies of the pharmaceutical or biotechnology industry treat the science of drug discovery as if i...
In order to appreciate the revolutionary changes taking place in the drug sciences, as well as understand the fundamental management and economic challenges of ...
If we want to understand how the drug and biotechnology business works and what makes it different, we need to understand which characteristics of the R&D proce...
What types of firms compete in the biotechnology segment? How have these changed over time? What kind of strategies have they pursued? And what capabilities do ...